Mereo BioPharma Group PLC ADR (MREO) is a biotechnology company listed on US.
Latest reported MREO revenue for 2026-06-30 was $0. Net income was -$7.0M. Revenue was down 100.0% from 2026-03-31 to 2026-06-30. MREO currently screens at market cap $48.7M.
Use this MREO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the MREO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the MREO SEC filings page. Lician reads the product cache first so this HTML stays unique to Mereo BioPharma Group PLC ADR even when a live quote feed is slow.
Latest cached year on this hub. Full MREO income, balance, and cash tables.